Zivo Bioscience
(ZIVO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,973 | -8,745 | -6,105 | -4,100 | -2,028 |
| Depreciation Amortization | -103 | -694 | -644 | -366 | -116 |
| Accounts payable and accrued liabilities | 180 | -164 | -47 | -247 | -134 |
| Other Working Capital | -295 | -355 | -494 | -770 | -1,288 |
| Other Operating Activity | 62 | 2,856 | 1,634 | 1,315 | 705 |
| Operating Cash Flow | $-2,129 | $-7,103 | $-5,656 | $-4,167 | $-2,862 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 606 | 629 | N/A | N/A | 629 |
| Debt Issued | N/A | N/A | 629 | 629 | N/A |
| Debt Repayment | N/A | N/A | -489 | -279 | N/A |
| Other Financing Activity | -67 | -629 | 0 | 0 | -70 |
| Financing Cash Flow | $538 | $N/A | $140 | $349 | $559 |
| Beginning Cash Position | 1,799 | 8,902 | 8,902 | 8,902 | 8,902 |
| End Cash Position | 209 | 1,799 | 3,386 | 5,084 | 6,599 |
| Net Cash Flow | $-1,591 | $-7,103 | $-5,516 | $-3,818 | $-2,303 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,129 | -7,103 | -5,656 | -4,167 | -2,862 |
| Free Cash Flow | -2,129 | -7,103 | -5,656 | -4,167 | -2,862 |